Luoxin Pharmaceuticals Group Stock Co Ltd - ESG Rating & Company Profile powered by AI
Other corporations in the scoring industry group for Luoxin Pharmaceuticals Group Stock Co Ltd are shown. This analysis of Luoxin Pharmaceuticals Group Stock Co Ltd incorporates intelligence from across the internet as well as from public documents by Luoxin Pharmaceuticals Group Stock Co Ltd. The SDG score for Luoxin Pharmaceuticals Group Stock Co Ltd indicates its transparency towards the United Nations SDGs.
Luoxin Pharmaceuticals Group Stock Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Luoxin Pharmaceuticals Group Stock Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Luoxin Pharmaceuticals Group Stock Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Luoxin Pharmaceuticals Group Stock Co Ltd disclose current and historical energy intensity?
Does Luoxin Pharmaceuticals Group Stock Co Ltd report the average age of the workforce?
Does Luoxin Pharmaceuticals Group Stock Co Ltd reference operational or capital allocation in relation to climate change?
Does Luoxin Pharmaceuticals Group Stock Co Ltd disclose its ethnicity pay gap?
Does Luoxin Pharmaceuticals Group Stock Co Ltd disclose cybersecurity risks?
Does Luoxin Pharmaceuticals Group Stock Co Ltd offer flexible work?
Does Luoxin Pharmaceuticals Group Stock Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Luoxin Pharmaceuticals Group Stock Co Ltd disclose the number of employees in R&D functions?
Does Luoxin Pharmaceuticals Group Stock Co Ltd conduct supply chain audits?
Does Luoxin Pharmaceuticals Group Stock Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Luoxin Pharmaceuticals Group Stock Co Ltd conduct 360 degree staff reviews?
Does Luoxin Pharmaceuticals Group Stock Co Ltd disclose the individual responsible for D&I?
Does Luoxin Pharmaceuticals Group Stock Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Luoxin Pharmaceuticals Group Stock Co Ltd disclose current and / or historical scope 2 emissions?
Does Luoxin Pharmaceuticals Group Stock Co Ltd disclose water use targets?
Does Luoxin Pharmaceuticals Group Stock Co Ltd have careers partnerships with academic institutions?
Did Luoxin Pharmaceuticals Group Stock Co Ltd have a product recall in the last two years?
Does Luoxin Pharmaceuticals Group Stock Co Ltd disclose incidents of discrimination?
Does Luoxin Pharmaceuticals Group Stock Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Luoxin Pharmaceuticals Group Stock Co Ltd issued a profit warning in the past 24 months?
Does Luoxin Pharmaceuticals Group Stock Co Ltd disclose parental leave metrics?
Does Luoxin Pharmaceuticals Group Stock Co Ltd disclose climate scenario or pathway analysis?
Does Luoxin Pharmaceuticals Group Stock Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Luoxin Pharmaceuticals Group Stock Co Ltd disclose the pay ratio of women to men?
Does Luoxin Pharmaceuticals Group Stock Co Ltd support suppliers with sustainability related research and development?
Does Luoxin Pharmaceuticals Group Stock Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Luoxin Pharmaceuticals Group Stock Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Luoxin Pharmaceuticals Group Stock Co Ltd involved in embryonic stem cell research?
Does Luoxin Pharmaceuticals Group Stock Co Ltd disclose GHG and Air Emissions intensity?
Does Luoxin Pharmaceuticals Group Stock Co Ltd disclose its waste policy?
Does Luoxin Pharmaceuticals Group Stock Co Ltd report according to TCFD requirements?
Does Luoxin Pharmaceuticals Group Stock Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Luoxin Pharmaceuticals Group Stock Co Ltd disclose energy use targets?
Does Luoxin Pharmaceuticals Group Stock Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Luoxin Pharmaceuticals Group Stock Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Luoxin Pharmaceuticals Group Stock Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Luoxin Pharmaceuticals Group Stock Co., Ltd. engages in the research and development, manufacture, and trading of drugs in China. The company provides antiviral, anti-infective, respiratory and digestive system, nervous and endocrine system, cardiovascular system, oncology, and anti-allergic APIs and intermediates, as well as antipyretic, analgesics, and anti-inflammatory APIs and intermediates. It also offers medical treatment and health services. The company was formerly known as Zhejiang Doyin Pump Industry Co., Ltd. and changed its name to Luoxin Pharmaceuticals Group Stock Co., Ltd. in April 2020. Luoxin Pharmaceuticals Group Stock Co., Ltd. is based in Linyi, China.